Conference Coverage

Data Presented on ISIS 5320 Anti-HIV Compound

Published in AIDS Weekly, February 13th, 1995

Isis Pharmaceuticals, Carlsbad, California, announced that data were presented showing that ISIS 5320 inhibits HIV viral replication in the SCID-hu mouse model of HIV infection, developed by Systemix Inc.

The data were presented at the 2nd National Conference on Human Retroviruses and Related Infections, held in Washington, D.C., January 29-February 2, 1995.

The SCID-hu mouse model is used by the U.S. National Institute of Allergy and Infectious Diseases to evaluate compounds exhibiting promising in vitro results against HIV-1. SCID-hu mice are immunodeficient mice that are transplanted with human fetal liver and thymus tissue. HIV-1 is injected...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1995-02-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry